Video

Q&A With Bruce Trapp, PhD From the Cleveland Clinic: Digging Deeper Into Progressive Multiple Sclerosis

Author(s):

More may be known about the relapsing form of multiple sclerosis but researchers are working to learn about the progressive form of the disease as well. That includes looking for potential tools to stop neurological degeneration from harming patients.

More may be known about the relapsing form of multiple sclerosis but researchers are working to learn about the progressive form of the disease as well. That includes looking for potential tools to stop neurological degeneration from harming patients.

Bruce D. Trapp, PhD, from the Cleveland Clinic and Lerner Research Institute discussed what research is being done on the lesser known condition during the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis. Trapp said there is a belief in the field that work should focus on progressive multiple sclerosis to look for targets that could help patients with this condition.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.